<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xml:lang="EN" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Dent</journal-id><journal-id journal-id-type="publisher-id">Eur J Dent</journal-id><journal-title>European Journal of Dentistry</journal-title><issn pub-type="ppub">1305-7456</issn><issn pub-type="epub">1305-7464</issn><publisher><publisher-name>Dental Investigations Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19212526</article-id><article-id pub-id-type="pmc">2633171</article-id><article-id pub-id-type="publisher-id">0020142</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>The Bi-Directional Relationship between Periodontal Disease and Hyperlipidemia</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fentoglu</surname><given-names>Ozlem</given-names></name><xref ref-type="aff" rid="af1-0020142">a</xref><xref ref-type="corresp" rid="c1-0020142"/></contrib><contrib contrib-type="author"><name><surname>Bozkurt</surname><given-names>F. Yesim</given-names></name><xref ref-type="aff" rid="af2-0020142">b</xref></contrib></contrib-group><aff id="af1-0020142"><label>a</label> Assist. Professor, S&#x000fc;leyman Demirel University, Faculty of Dentistry, Department of Periodontology, Isparta, Turkey</aff><aff id="af2-0020142"><label>b</label> Professor, S&#x000fc;leyman Demirel University, Faculty of Dentistry, Department of Periodontology, Isparta, Turkey</aff><author-notes><corresp id="c1-0020142">Corresponding author: Dr. Ozlem Fentoglu, Suleyman Demirel Universitesi Dishekimligi Fakultesi, Periodontoloji Anabilim Dali, Dogu Kampusu, 32260, Isparta, Turkey., Phone: + 90 246 2113322 Fax : + 90 246 2370607, E-mail:<email>ofentoglu@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2008</year></pub-date><volume>2</volume><fpage>142</fpage><lpage>146</lpage><permissions><copyright-statement>Copyright 2008 European Journal of Dentistry. All rights reserved.</copyright-statement><copyright-year>2008</copyright-year></permissions><abstract><p>It has been proposed for several decades that infections may be responsible for the accelerated development of atherosclerosis. The initiation of the atherosclerotic plaque is ascribed to focal accumulation of lipids. This explains the importance of plasma lipids in the development of atherosclerosis. Recent reports point towards a possible association between periodontal disease and increased risk for cardiovascular disease. Thus, periodontitis and cardiovascular disease may share common risk factors, and association between periodontitis and coronary heart disease may be due to the elevated levels of plasma lipids. Epidemiological and clinical studies have also suggested that there is a relationship between periodontal disease and impaired lipid metabolism. In this review, we summarized the potential link mechanisms in the association between periodontal infection and serum lipids.</p></abstract><kwd-group><kwd>Periodontal disease</kwd><kwd>Hyperlipidemia</kwd><kwd>Lipid metabolism</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Periodontal diseases are a group of inflammatory diseases in which Gram-negative microorganisms and their products are the principal etiologic agents.<xref ref-type="bibr" rid="b1-0020142">1</xref> These microorganisms, particularly <italic>Porphyromonas gingivalis (P. gingivalis),</italic> produce endotoxins in the form of lipopolysaccharides (LPS) that are instrumental in generating a host-mediated tissue destructive immune response.<xref ref-type="bibr" rid="b2-0020142">2</xref> Recent studies indicate that periodontal disease may have profound effects on systemic health. Subjects with periodontal disease may have a higher risk for cardiovascular disease when compared to subjects with a healthy periodontium.<xref ref-type="bibr" rid="b3-0020142">3</xref></p><p>The biological plausibility for a periodontal infection-systemic disease link can be briefly explained as follows. Periodontal infection causes bacteraemia and endotoxaemia and promotes systemic inflammatory and immune responses that may roles in systemic disease. Periodontal pathogens express specific virulence factors that can affect atherogenic events. Finally, periodontal pathogens have also been isolated from non-oral tissues like atheromatous plaques.<xref ref-type="bibr" rid="b4-0020142">4</xref></p><p>The consequence of these findings, recent researches have been focused the association of periodontal infection and systemic disease, and in this relationship in the alterations of lipid metabolism have been revealed as a potentially inductive factor.<xref ref-type="bibr" rid="b5-0020142">5</xref></p></sec><sec><title>A. POTENTIAL MECHANISMS IN THE ASSOCIATION BETWEEN PERIODONTAL DISEASE AND HYPERLIPIDEMIA</title><sec><title>1. Infection and hyperlipidemia</title><p>Previously, it was thought that serum lipid alterations were related to the underlying pathological conditions rather than the infectious process. However, recent studies have demonstrated that lipid metabolism may be altered by chronic local and acute systemic infections which are involved in the plasma concentrations of unregulated cytokines and hormones. The main features of this catabolic state are lipid oxidation and elevated free fatty acids, triglycerides and low density lipoprotein (LDL) cholesterol.<xref ref-type="bibr" rid="b6-0020142">6</xref>,<xref ref-type="bibr" rid="b7-0020142">7</xref></p><p>Studies in humans and animals have shown a number of cytokines such as tumor necrosis factor alpha (TNF-&#x003b1;) and interleukin-1 beta (IL-1&#x003b2;) are produced in response to systemic Gram-negative LPS exposure. It is believed that these cytokines exert effects on lipid metabolism by influencing production of other cytokines, altering hemodynamics/aminoacid utilization of various tissues involved in lipid metabolism,<xref ref-type="bibr" rid="b8-0020142">8</xref>,<xref ref-type="bibr" rid="b9-0020142">9</xref> or modifying the hypothalamic-pituitary-adrenal axis increasing plasma concentrations of adrenocorticotropic hormone, cortisol, adrenaline, noradrenaline, and glucagon.<xref ref-type="bibr" rid="b10-0020142">10</xref>&#x02013;<xref ref-type="bibr" rid="b12-0020142">12</xref> Thus, through action of TNF-&#x003b1; and IL-1&#x003b2;, exposure to microorganisms/ endotoxin results in elevated levels of free fatty acids, LDL and triglyceride. These elevations in serum lipids are thought to arise from enhanced hepatic lipogenesis,<xref ref-type="bibr" rid="b13-0020142">13</xref>,<xref ref-type="bibr" rid="b14-0020142">14</xref> increased adipose tissue lipolysis/blood flow, increased synthesis or reduced clearance of triglyceride, and reduced clearance of LDL due to reductions in lipoprotein lipase activity.<xref ref-type="bibr" rid="b15-0020142">15</xref>,<xref ref-type="bibr" rid="b16-0020142">16</xref> Thus, any condition producing elevations in serum TNF-&#x003b1; and IL-1&#x003b2; has potential to cause hyperlipidemia.</p><p>Lipids may interact directly with the macrophage cell membrane, interfering with membrane-bound receptors and enzyme systems, altering macrophage gene expression for pro-inflammatory cytokines such as TNF-&#x003b1; and IL-1&#x003b2; and essential polypeptide growth factors such as platelet-derived growth factor (PDGF), transforming growth factor beta 1 (TGF-&#x003b2;1) and basic fibroblast growth factor (bFGF).<xref ref-type="bibr" rid="b17-0020142">17</xref>,<xref ref-type="bibr" rid="b18-0020142">18</xref> Additionally, serum lipids, whether induced by diabetes, or diet increase polymorphonuclear leukocyte (PMN) production of pro-inflammatory cytokines and inhibit macrophage production of essential polypeptide growth factors impairing the wound healing process. Furthermore, hyperlipidemia may be more important than hyperglycemia relative to the hyper-responsive monosytic phenotype<xref ref-type="bibr" rid="b19-0020142">19</xref>&#x02013;<xref ref-type="bibr" rid="b21-0020142">21</xref> and development of many diabetic complications.<xref ref-type="bibr" rid="b22-0020142">22</xref></p></sec><sec><title>2. Interactions between bacterial lipopolysaccharides and serum lipoproteins</title><sec><title>a. Bacterial infections, lipoprotein levels and lipoprotein metabolism</title><p>The most commonly observed infection-induced lipid abnormalities in man and experimental animals are increased triglyceride and very low density lipoprotein (VLDL) levels<xref ref-type="bibr" rid="b23-0020142">23</xref> and decreased high density lipoprotein (HDL) cholesterol levels.<xref ref-type="bibr" rid="b24-0020142">24</xref> A decrease in total and LDL cholesterol levels has also been reported during severe bacterial infections.<xref ref-type="bibr" rid="b25-0020142">25</xref> However, in rodents and rabbits administration of LPS often leads to hypercholesterolemia.<xref ref-type="bibr" rid="b23-0020142">23</xref> Hepatic and lipoprotein lipase activity levels decreased during acute infections.<xref ref-type="bibr" rid="b26-0020142">26</xref>, <xref ref-type="bibr" rid="b27-0020142">27</xref></p></sec><sec><title>b. Abnormalities in lipid and lipoprotein levels: cytokine mediated effects</title><p>Tumor necrosis factor (TNF) induces a rapid increase in serum triglyceride, VLDL and cholesterol levels. Although the mechanism by which TNF increases serum cholesterol levels is unknown, the increase in hepatic cholesterol synthesis may be due to an increase in the activity of 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase.<xref ref-type="bibr" rid="b13-0020142">13</xref></p></sec><sec><title>c. LPS-LDL interactions: effects on lipoprotein metabolism</title><p>Low concentrations of LPS inhibit the expression of scavenger receptor activity on human monocyte-derived macrophages but had no effect on LDL receptor activity.<xref ref-type="bibr" rid="b28-0020142">28</xref> Furthermore, when LPS is complexed with LDL the inhibitory effect of LPS on scavenger receptor activity is markedly enhanced.<xref ref-type="bibr" rid="b29-0020142">29</xref> Besides affecting scavenger and LDL receptors, LPS affects LDL metabolism by precluding its hydrolysis. Furthermore, LPS binds to lipoproteins in direct proportion to their cholesterol content and that the LDL-LPS complex once taken by macrophages is not degraded.<xref ref-type="bibr" rid="b29-0020142">29</xref></p></sec><sec><title>d. LPS, release of cytokines and LDL modification</title><p>Though it was demonstrated that LPS causes widespread endotelial damage, in hypercholesterolemic status this damage seems to be more severe and persistent.<xref ref-type="bibr" rid="b30-0020142">30</xref> In animals maintained on high cholesterol diets for the duration of the experiment, arteriosclerotic lesions may not be detectable until 3 months after administration of a single small dose of LPS, even so, LPS cause the initial endothelial damage, and hypercholesterolemia may interrupt the normal repair process.<xref ref-type="bibr" rid="b31-0020142">31</xref></p><p>Another possible mechanism by which LPS contributes to the development of atherosclerosis is the oxidative modification of LDL induced during macrophage activation. Several possible pathogenic roles with marked importance in the development of atherosclerosis may be attributed to oxidized LDL (ox-LDL). First, ox-LDL is taken up by macrophage scavenger receptors<xref ref-type="bibr" rid="b32-0020142">32</xref>,<xref ref-type="bibr" rid="b33-0020142">33</xref> leading to the transformation of macrophages into foam cells, the hallmark of the atherosclerotic process. Second, ox-LDL is cytotoxic for endothelial cells<xref ref-type="bibr" rid="b34-0020142">34</xref> and is a potent chemo-attractant for circulating human monocytes.<xref ref-type="bibr" rid="b33-0020142">33</xref></p></sec></sec><sec><title>3. Lipoprotein-associated inflammatory proteins: mediators of cardiovascular disease</title><p>Plasma lipoproteins are largely involved in the transport of acute phase reactant proteins such as C-reactive protein (CRP), serum amyloid which greatly A and secretory phospholipase A<sub>2</sub> increases the risk of atherosclerosis.<xref ref-type="bibr" rid="b35-0020142">35</xref></p><p>The acute phase reactions, associated with injury, inflammation, or sepsis, markedly affect the concentration and composition of plasma lipids and lipoproteins. Hepatic production of triglycerides and LDL formation are increased, but do not necessarily result in high plasma triglyceride levels. In contrast, all conditions lower plasma cholesterol by decreasing its content in both low-density and high-density lipoproteins. In addition, substantial changes in protein and lipid composition of lipoproteins are observed that may redefine the function of these particles, but also increase their atherogenic and inflammatory properties.<xref ref-type="bibr" rid="b36-0020142">36</xref></p></sec><sec><title>4. Modulatory effects of dietary lipids on immune system functions</title><p>The immune response of both humans and animals may be influenced by several essential nutrients, which modify the immune system functions. Dietary lipids or free fatty acids may be modulate the immune system through a great number of mechanisms that include reduction of lymphocyte proliferation, reduction of cytokine synthesis, increase of phagocytic activity,modification of natural killer (NK) cell activity and so on. This modulation may be associated with changes in the cell membrane due to dietary fatty acid manipulation. Fatty acids may be incorporated into the plasma membrane after dietary lipid administration, so that the composition of lipids in this cellular structure will reflect the composition of dietary lipids.<xref ref-type="bibr" rid="b37-0020142">37</xref> Because of this incorporation, the phospholipid profiles associated with plasma membrane of lymphocytes, monocytes/macrophages or polymorphonuclear cells may be altered by dietary lipids.<xref ref-type="bibr" rid="b38-0020142">38</xref>,<xref ref-type="bibr" rid="b39-0020142">39</xref></p><p>Diets including polyunsaturated fatty acids, such as eicosapentaenoic or docosahexaenoic acids, suppress the mitogenic response of lymphocytes to a greater extent than diets rich in saturated fatty acids.<xref ref-type="bibr" rid="b40-0020142">40</xref></p><p>Fatty acids may regulate cytokine production and in fact cytokine modulation by fatty acids seems to be responsible for the reduction of lymphocyte proliferation in both animals and humans. Cytokines such as IL-1 and TNF are important mediators of inflammation and dietary fatty acids have been demonstrated to be substances capable of reducing the pro-inflammatory response induced by IL-1 and TNF.<xref ref-type="bibr" rid="b41-0020142">41</xref>&#x02013;<xref ref-type="bibr" rid="b43-0020142">43</xref> The mechanisms involved in the modification of cytokine synthesis remain unclear as yet, but a possible explanation could be found in the regulation at the transcriptional level, that is, reduction of cytokine mRNA production by polyunsaturated fatty acids.<xref ref-type="bibr" rid="b44-0020142">44</xref> Dietary fatty acids may also be able to modulate activity of NK cells participating in protection against virus, intracellular bacteria or tumoral cells. Diets containing fish oil or olive oil produce the greatest percentage of NK cell activity inhibition in comparison with diets rich in saturated fatty acids or n-6 polyunsaturated fatty acids.<xref ref-type="bibr" rid="b45-0020142">45</xref>, <xref ref-type="bibr" rid="b46-0020142">46</xref> However, there are several reports are found, eicosanoids such as prostaglandins, leukotrienes or lipoxins may play important role in this mechanism.<xref ref-type="bibr" rid="b47-0020142">47</xref>&#x02013;<xref ref-type="bibr" rid="b49-0020142">49</xref> It has been reported that unsaturated fatty acids increase phagocytosis which is an important mechanism in many cells for the elimination of microorganisms or foreign particles.<xref ref-type="bibr" rid="b42-0020142">42</xref>,<xref ref-type="bibr" rid="b50-0020142">50</xref></p><p>Mechanisms involved in fatty acid modulation are membrane fluidity, production of lipid peroxides, eicosanoid synthesis and influence on gene regulation. As a result of changes in the phospholipids fatty acid composition due to dietary lipid manipulation, the fluidity of the cell membrane may change. Fatty acids have inhibitory effects on cellular proliferation due to lipid peroxidation which are toxic to cells. Dietary fats have an important role in decreasing antioxidant enzyme mRNA levels and enhancing free radical-induced tissue damage. Fatty acids undergo enzymatic degradation to yield eicosanoid family (prostaglandins, leukotrienes or lipoxins) participating in inflammatory processes and are also related to immunomodulatory effects, which act as lipid mediators.<xref ref-type="bibr" rid="b51-0020142">51</xref></p></sec></sec><sec><title>B. PERIODONTITIS AND HYPERLIPIDEMIA</title><p>The alterations in immune cell phenotype due to serum lipids and elevation in serum pro-inflammatory cytokines such as TNF-&#x003b1; and IL-1&#x003b2; through periodontitis as a chronic gram (&#x02212;) infection verified substantial evidences supporting this bidirectional relationship.</p><p>Hyperlipidemia, arising from a high-fat diet or metabolic disorders such as type 2 diabetes, has a dysregulatory effect on immune system cells and on wound healing and as a result, it increases the susceptibility to periodontitis and other infections. This condition needs a particular threshold level of circulating lipids for every individual, above which can lead to this dysregulatory effect within the gingival mucosa and elsewhere.<xref ref-type="bibr" rid="b5-0020142">5</xref></p><p>It has been reported that consumption of a typical high-fat American breakfast (fried eggs, bacon, potatoes) or a defined saturated-fat-rich meal (i.e. ice cream) leads to functional abnormalities in PMNs.<xref ref-type="bibr" rid="b52-0020142">52</xref> A protective role for PMNs in the early response to periodontal infection is supported by compelling experiments in nature, wherein subjects with impairments of PMN function<xref ref-type="bibr" rid="b53-0020142">53</xref> or number<xref ref-type="bibr" rid="b54-0020142">54</xref> have more acute and severe periodontitis. So, PMNs primed by endotoxin or other activating agents, including dietary lipids may play a major role in the pathogenesis of periodontitis.<xref ref-type="bibr" rid="b55-0020142">55</xref> A possible role of hyperlipidemia for periodontitis is also obvious from several studies. Hyperlipidemia is known to cause a hyperactivity of white blood cells.<xref ref-type="bibr" rid="b56-0020142">56</xref>,<xref ref-type="bibr" rid="b57-0020142">57</xref> Hyperactivity of white cells, e.g., increased production of oxygen radicals, have been shown to be frequently associated with progressive periodontitis in adults.<xref ref-type="bibr" rid="b58-0020142">58</xref> In animals feeding a cholesterol-rich diet have caused to periodontitis.<xref ref-type="bibr" rid="b59-0020142">59</xref></p><p>In an animal model, Maglakelidze et al<xref ref-type="bibr" rid="b60-0020142">60</xref> have reported significant changes in extracellular matrix and gingival mucous cells as well as in microcirculatory bed components in hypercholesterolemia. Hypercholesterolemia damages endotheliocytes, subendothelial zone and basal membrane permeability. The contact of lymphocytes and plasmocytes with the vascular wall confirms the trigger role of the vascular factor in damaging of periodontal complex.</p><p>There are several studies which report significant association between plasma lipid levels and the severity of the periodontal disease.<xref ref-type="bibr" rid="b61-0020142">61</xref>&#x02013;<xref ref-type="bibr" rid="b63-0020142">63</xref> While some authors mentioned that there were significant correlations between periodontal status and cholesterol levels,<xref ref-type="bibr" rid="b64-0020142">64</xref>&#x02013;<xref ref-type="bibr" rid="b69-0020142">69</xref> others indicate that there were significant associations between triglyceride level and periodontal disease.<xref ref-type="bibr" rid="b70-0020142">70</xref>&#x02013;<xref ref-type="bibr" rid="b72-0020142">72</xref></p><p>The studies which trying the effect of periodontal therapy on serum lipids and lipoprotein associated inflammatuar mediators<xref ref-type="bibr" rid="b73-0020142">73</xref>&#x02013;<xref ref-type="bibr" rid="b76-0020142">76</xref> also suggested that the treatment of periodontal disease have beneficial effects on lipid metabolism. In one study conducted in systemically healthy subjects with periodontitis, Pussinen et al<xref ref-type="bibr" rid="b73-0020142">73</xref> stated that periodontitis is associated with macrophage activation via increased serum LPS concentration. Additionally, there was a significant increase in the ratio of HDL/LDL after periodontal treatment in this study. In another study, Pussinen et al<xref ref-type="bibr" rid="b74-0020142">74</xref> reported that there were statistically significant decreases in CRP and serum amyloid A levels after periodontal treatment in systemically healthy subjects with periodontitis. That study also suggested that periodontitis diminishes the anti-atherogenic potency of HDL and increase the risk for coronary heart disease.</p><p>L&#x000f6;sche et al<xref ref-type="bibr" rid="b75-0020142">75</xref> evaluated 32 patients with moderate to severe periodontitis before and 3 months after local periodontal treatment and they reported that treatment of periodontitis caused a significant reduction in the serum activity of lipoprotein-associated phospholipase A<sub>2</sub> which is believed to be an independent cardiovascular risk factor. In a similar study, 65 subjects presenting with severe (probing pocket depth greater than 6 mm and marginal alveolar bone loss greater than 30%), generalized (at least 50% of teeth affected) periodontitis were assessed and the 3 groups consisted of untreated control; standard periodontal therapy; and an intensive periodontal treatment including standard periodontal treatment with adjunctive local delivery of minocycline. In that study both standard periodontal therapy and intensive periodontal therapy resulted in significant reductions in serum CRP compared with the untreated control and the intensive periodontal therapy group also showed a decrease in total and LDL cholesterol after 2 months following the periodontal treatment.<xref ref-type="bibr" rid="b76-0020142">76</xref></p><p>Higher serum levels of total cholesterol, LDL-C and triglycerides have been found in subjects with periodontal disease,<xref ref-type="bibr" rid="b71-0020142">71</xref>,<xref ref-type="bibr" rid="b77-0020142">77</xref>,<xref ref-type="bibr" rid="b62-0020142">62</xref> and hyperlipidemic patients have a significantly higher percentage of sites with probing depth greater than 3.5 mm than subjects with normal metabolic status.<xref ref-type="bibr" rid="b78-0020142">78</xref> The interrelationship between periodontitis and hyperlipidemia provides an example for systemic disease predisposing to oral infection, and once the oral infection is established, it exacerbates systemic disease.</p></sec><sec sec-type="conclusions"><title>CONCLUSIONS</title><p>However, it is unclear whether the association of periodontal disease and impaired lipid metabolism is a cause-effect interrelationship, namely whether periodontitis induces higher serum lipid levels or higher serum lipid levels are predisposing factors for periodontitis, the association of these two phenomenons is widely discussed in the periodontal literature.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="b1-0020142"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Listgarten</surname><given-names>MA</given-names></name></person-group><article-title>Nature of periodontal diseases: Pathogenic mechanisms</article-title><source>J Periodont Res</source><year>1987</year><volume>22</volume><fpage>172</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">2955092</pub-id></citation></ref><ref id="b2-0020142"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cutler</surname><given-names>CW</given-names></name><name><surname>Kamlar</surname><given-names>JR</given-names></name><name><surname>Genco</surname><given-names>CA</given-names></name></person-group><article-title>Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis</article-title><source>Trends Microbiol</source><year>1995</year><volume>3</volume><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">7728384</pub-id></citation></ref><ref id="b3-0020142"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mattila</surname><given-names>KJ</given-names></name><name><surname>Nieminen</surname><given-names>MS</given-names></name><name><surname>Valtonen</surname><given-names>VV</given-names></name><name><surname>Rasi</surname><given-names>VP</given-names></name><name><surname>Kesaniemi</surname><given-names>YA</given-names></name><name><surname>Syrjala</surname><given-names>SL</given-names></name></person-group><article-title>Association between dental health and acute myocardial infarction</article-title><source>BMJ</source><year>1989</year><volume>298</volume><fpage>779</fpage><lpage>781</lpage><pub-id pub-id-type="pmid">2496855</pub-id></citation></ref><ref id="b4-0020142"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paquette</surname><given-names>DW</given-names></name></person-group><article-title>The periodontal infection-systemic disease link: A review of the truth or myth</article-title><source>J Int Acad Periodontol</source><year>2002</year><volume>4</volume><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">12670089</pub-id></citation></ref><ref id="b5-0020142"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iacopino</surname><given-names>AM</given-names></name><name><surname>Cutler</surname><given-names>CW</given-names></name></person-group><article-title>Pathophysiological relationships between periodontitis and systemic disease: Recent concepts involving serum lipids</article-title><source>J Periodontol</source><year>2000</year><volume>71</volume><fpage>1375</fpage><lpage>1384</lpage><pub-id pub-id-type="pmid">10972656</pub-id></citation></ref><ref id="b6-0020142"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopes-Virella</surname><given-names>MF</given-names></name></person-group><article-title>Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease</article-title><source>Eur Heart J</source><year>1993</year><volume>14</volume><fpage>118</fpage><lpage>124</lpage><pub-id pub-id-type="pmid">8131779</pub-id></citation></ref><ref id="b7-0020142"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samra</surname><given-names>JS</given-names></name><name><surname>Summers</surname><given-names>LKM</given-names></name><name><surname>Frayn</surname><given-names>KN</given-names></name></person-group><article-title>Sepsis and fat metabolism</article-title><source>Br J Surg</source><year>1996</year><volume>83</volume><fpage>1186</fpage><lpage>1196</lpage><pub-id pub-id-type="pmid">8983604</pub-id></citation></ref><ref id="b8-0020142"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukushima</surname><given-names>R</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name><name><surname>Taniwaka</surname><given-names>K</given-names></name></person-group><article-title>Different roles of IL-1 and TNF on hemodynamics, amino acid metabolism in dogs</article-title><source>Am J Physiol</source><year>1992</year><volume>262</volume><fpage>275</fpage><lpage>281</lpage></citation></ref><ref id="b9-0020142"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van der Poll</surname><given-names>T</given-names></name><name><surname>Romijn</surname><given-names>JA</given-names></name><name><surname>Endert</surname><given-names>E</given-names></name><name><surname>Borm</surname><given-names>JJ</given-names></name><name><surname>Buller</surname><given-names>HR</given-names></name><name><surname>Sauerwein</surname><given-names>HP</given-names></name></person-group><article-title>Tumor necrosis factor mimics the metabolic response to infection in healthy humans</article-title><source>Am J Physiol</source><year>1991</year><volume>261</volume><fpage>457</fpage><lpage>465</lpage></citation></ref><ref id="b10-0020142"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gwosdow</surname><given-names>AR</given-names></name><name><surname>Kumar</surname><given-names>MSA</given-names></name><name><surname>Bode</surname><given-names>HH</given-names></name></person-group><article-title>Interleukin-1 stimulation of the hypothalamic-pituitary-adrenal axis</article-title><source>Am J Physiol</source><year>1990</year><volume>258</volume><fpage>65</fpage><lpage>70</lpage></citation></ref><ref id="b11-0020142"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imura</surname><given-names>H</given-names></name><name><surname>Fukata</surname><given-names>J</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name></person-group><article-title>Cytokines and endocrine function: an interaction between the immune and neuroendocrine systems</article-title><source>Clin Endocrinol</source><year>1991</year><volume>35</volume><fpage>107</fpage><lpage>115</lpage></citation></ref><ref id="b12-0020142"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chrousos</surname><given-names>GP</given-names></name></person-group><article-title>The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation</article-title><source>N Engl J Med</source><year>1995</year><volume>332</volume><fpage>1351</fpage><lpage>1362</lpage><pub-id pub-id-type="pmid">7715646</pub-id></citation></ref><ref id="b13-0020142"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feingold</surname><given-names>KR</given-names></name><name><surname>Grunfeld</surname><given-names>C</given-names></name></person-group><article-title>Tumor necrosis factor alpha stimulates hepatic lipogenesis in the rat in vivo</article-title><source>J Clin Invest</source><year>1987</year><volume>80</volume><fpage>184</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">3597772</pub-id></citation></ref><ref id="b14-0020142"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kurpad</surname><given-names>A</given-names></name><name><surname>Khan</surname><given-names>K</given-names></name><name><surname>Calder</surname><given-names>AG</given-names></name></person-group><article-title>Effect of noradrenaline on glycerol turnover and lipolysis in the whole body and subcutaneous adipose tissue</article-title><source>Am J Physiol</source><year>1992</year><volume>263</volume><fpage>850</fpage><lpage>855</lpage></citation></ref><ref id="b15-0020142"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lanza-Jacoby</surname><given-names>S</given-names></name><name><surname>Tabares</surname><given-names>A</given-names></name></person-group><article-title>Triglyceride kinetics, tissue lipoprotein lipase, and liver lipogenesis in septic rats</article-title><source>Am J Physiol</source><year>1990</year><volume>258</volume><fpage>678</fpage><lpage>685</lpage></citation></ref><ref id="b16-0020142"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fried</surname><given-names>SK</given-names></name><name><surname>Zechner</surname><given-names>R</given-names></name></person-group><article-title>Tumor necrosis factor decreases human adipose tissue lipoprotein lipase mRNA levels, synthesis, and activity</article-title><source>J Lipid Res</source><year>1989</year><volume>30</volume><fpage>1917</fpage><lpage>1923</lpage><pub-id pub-id-type="pmid">2695592</pub-id></citation></ref><ref id="b17-0020142"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doxey</surname><given-names>DL</given-names></name><name><surname>Ng</surname><given-names>MC</given-names></name><name><surname>Dill</surname><given-names>RE</given-names></name><name><surname>Iacopino</surname><given-names>AM</given-names></name></person-group><article-title>Platelet-derived growth factor levels in wounds of diabeticrats</article-title><source>Life Sci</source><year>1995</year><volume>57</volume><fpage>1111</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">7658918</pub-id></citation></ref><ref id="b18-0020142"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>X</given-names></name><name><surname>Newman</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>B</given-names></name><name><surname>Nares</surname><given-names>S</given-names></name><name><surname>Ordonez</surname><given-names>G</given-names></name><name><surname>Iacopino</surname><given-names>AM</given-names></name></person-group><article-title>In vitro alteration of macrophage phenotype and function by serum lipids</article-title><source>Cell Tissue Res</source><year>1999</year><volume>296</volume><fpage>331</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">10382275</pub-id></citation></ref><ref id="b19-0020142"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>TE</given-names></name><name><surname>Jackson</surname><given-names>RL</given-names></name><name><surname>Ohlweiler</surname><given-names>DF</given-names></name><name><surname>Ku</surname><given-names>G</given-names></name></person-group><article-title>Multiple lipid oxidation products in low density lipoproteins induce interleukin-1 beta release from human blood mononuclear cells</article-title><source>J Lipid Res</source><year>1994</year><volume>35</volume><fpage>417</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">8014577</pub-id></citation></ref><ref id="b20-0020142"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van der Poll</surname><given-names>T</given-names></name><name><surname>Braxton</surname><given-names>CC</given-names></name><name><surname>Coyle</surname><given-names>SM</given-names></name><name><surname>Calvano</surname><given-names>SE</given-names></name><name><surname>Hack</surname><given-names>CE</given-names></name><name><surname>Lowry</surname><given-names>SF</given-names></name></person-group><article-title>Effect of hypertriglyceridemia on endotoxin response in humans</article-title><source>Infect Immun</source><year>1995</year><volume>63</volume><fpage>3396</fpage><lpage>4000</lpage><pub-id pub-id-type="pmid">7642268</pub-id></citation></ref><ref id="b21-0020142"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jovinge</surname><given-names>S</given-names></name><name><surname>Ares</surname><given-names>M</given-names></name><name><surname>Kallin</surname><given-names>B</given-names></name><name><surname>Nilsson</surname><given-names>J</given-names></name></person-group><article-title>Human monocytes/ macrophages release TNF-&#x003b1; in response to ox-LDL</article-title><source>Arterioscler Thromb Vasc Biol</source><year>1996</year><volume>16</volume><fpage>1573</fpage><lpage>1579</lpage><pub-id pub-id-type="pmid">8977464</pub-id></citation></ref><ref id="b22-0020142"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dutta-Roy</surname><given-names>AK</given-names></name></person-group><article-title>Insulin mediated processes in platelets, erythrocytes and monocytes/macrophages: effects of essential fatty acid metabolism</article-title><source>Prostaglandins Leukot Essent Fatty Acids</source><year>1994</year><volume>51</volume><fpage>385</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">7708803</pub-id></citation></ref><ref id="b23-0020142"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cabana</surname><given-names>VG</given-names></name><name><surname>Siegel</surname><given-names>JW</given-names></name><name><surname>Sabesin</surname><given-names>SM</given-names></name></person-group><article-title>Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins</article-title><source>J Lipid Res</source><year>1989</year><volume>30</volume><fpage>39</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">2493057</pub-id></citation></ref><ref id="b24-0020142"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kerttula</surname><given-names>Y</given-names></name><name><surname>Vaara</surname><given-names>M</given-names></name><name><surname>Phyh&#x000e4;l&#x000e4;</surname><given-names>L</given-names></name></person-group><article-title>Effect of bacterial lipopolysaccharide on serum high density lipoprotein cholesterol in rabbits</article-title><source>Atherosclerosis</source><year>1984</year><volume>52</volume><fpage>123</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">6380509</pub-id></citation></ref><ref id="b25-0020142"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Akerlund</surname><given-names>B</given-names></name><name><surname>Carlson</surname><given-names>LA</given-names></name><name><surname>Jarstrand</surname><given-names>C</given-names></name></person-group><article-title>Dyslipoproteinemia in patients with severe bacterial infections</article-title><source>Scand J Infec Dis</source><year>1986</year><volume>18</volume><fpage>539</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">3468606</pub-id></citation></ref><ref id="b26-0020142"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>C</given-names></name><name><surname>Ramos</surname><given-names>A</given-names></name></person-group><article-title>Lipids, lipoproteins, and apoproteins in serum during infection</article-title><source>Clin Chem</source><year>1986</year><volume>32</volume><fpage>142</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">3940695</pub-id></citation></ref><ref id="b27-0020142"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sammalkorpi</surname><given-names>K</given-names></name><name><surname>Valtonen</surname><given-names>V</given-names></name><name><surname>Kerttula</surname><given-names>Y</given-names></name><name><surname>Nikkila</surname><given-names>E</given-names></name><name><surname>Taskinen</surname><given-names>MR</given-names></name></person-group><article-title>Changes in serum lipoprotein pattern induced by acute infections</article-title><source>Metabolism</source><year>1988</year><volume>37</volume><fpage>859</fpage><lpage>865</lpage><pub-id pub-id-type="pmid">3419323</pub-id></citation></ref><ref id="b28-0020142"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Lenten</surname><given-names>BJ</given-names></name><name><surname>Fogelman</surname><given-names>AM</given-names></name><name><surname>Seager</surname><given-names>J</given-names></name><name><surname>Ribi</surname><given-names>E</given-names></name><name><surname>Haberland</surname><given-names>ME</given-names></name><name><surname>Edwards</surname><given-names>PA</given-names></name></person-group><article-title>Bacterial endotoxin selectively prevents the expression of scavenger receptor activity on human monocyte-macrophages</article-title><source>J Immunol</source><year>1985</year><volume>134</volume><fpage>3718</fpage><lpage>3721</lpage><pub-id pub-id-type="pmid">2985693</pub-id></citation></ref><ref id="b29-0020142"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Lenten</surname><given-names>BJ</given-names></name><name><surname>Fogelman</surname><given-names>AM</given-names></name><name><surname>Haberland</surname><given-names>ME</given-names></name><name><surname>Edwards</surname><given-names>PA</given-names></name></person-group><article-title>The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide</article-title><source>Proce Natl Acad Sci USA</source><year>1986</year><volume>83</volume><fpage>2704</fpage><lpage>2708</lpage></citation></ref><ref id="b30-0020142"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reidy</surname><given-names>MA</given-names></name><name><surname>Bowyer</surname><given-names>DE</given-names></name></person-group><article-title>Distortion of endthelial repair. The effect of hypercholesterolemia on regeneration of aortic endothelium following injury by endotoxin</article-title><source>Atherosclerosis</source><year>1978</year><volume>29</volume><fpage>459</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">666889</pub-id></citation></ref><ref id="b31-0020142"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>SC</given-names></name><name><surname>Lee</surname><given-names>WM</given-names></name><name><surname>Jarmolych</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>KT</given-names></name><name><surname>Thomas</surname><given-names>WA</given-names></name></person-group><article-title>Rapid production of advanced atherosclerosis in swine by a combination of endothelial injury and cholesterol feeding</article-title><source>Exp Mol Pathol</source><year>1973</year><volume>18</volume><fpage>369</fpage><lpage>379</lpage><pub-id pub-id-type="pmid">4708314</pub-id></citation></ref><ref id="b32-0020142"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yla-Herttuala</surname><given-names>S</given-names></name></person-group><article-title>Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis</article-title><source>Ann Med</source><year>1991</year><volume>23</volume><fpage>561</fpage><lpage>567</lpage><pub-id pub-id-type="pmid">1721825</pub-id></citation></ref><ref id="b33-0020142"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Witztum</surname><given-names>JL</given-names></name><name><surname>Steinberg</surname><given-names>D</given-names></name></person-group><article-title>Role of oxidized low density lipoprotein in atherogenesis</article-title><source>J Clin Invest</source><year>1991</year><volume>88</volume><fpage>1785</fpage><lpage>1792</lpage><pub-id pub-id-type="pmid">1752940</pub-id></citation></ref><ref id="b34-0020142"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cathcart</surname><given-names>MK</given-names></name><name><surname>McNally</surname><given-names>AK</given-names></name><name><surname>Morel</surname><given-names>DW</given-names></name><name><surname>Chisolm</surname><given-names>GM</given-names></name></person-group><article-title>The role of superoxide anion in human monocyte-mediated oxidation and conversion of LDL to a cytotoxin</article-title><source>J Immunol</source><year>1988</year><volume>142</volume><fpage>1963</fpage><lpage>1969</lpage><pub-id pub-id-type="pmid">2537865</pub-id></citation></ref><ref id="b35-0020142"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chait</surname><given-names>A</given-names></name><name><surname>Han</surname><given-names>CY</given-names></name><name><surname>Oram</surname><given-names>JF</given-names></name><name><surname>Heinecke</surname><given-names>JW</given-names></name></person-group><article-title>Lipoprotein- associated inflammatory proteins: markers or mediators of cardiovascular disease?</article-title><source>J Lipid Res</source><year>2005</year><volume>46</volume><fpage>389</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">15722558</pub-id></citation></ref><ref id="b36-0020142"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carpentier</surname><given-names>YA</given-names></name><name><surname>Scruel</surname><given-names>O</given-names></name></person-group><article-title>Changes in the concentration and composition of plasma lipoproteins during the acute phase response</article-title><source>Curr Opin Clin Nutr Metab Care</source><year>2002</year><volume>5</volume><fpage>153</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">11844981</pub-id></citation></ref><ref id="b37-0020142"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clamp</surname><given-names>AG</given-names></name><name><surname>Ladha</surname><given-names>S</given-names></name><name><surname>Clark</surname><given-names>DC</given-names></name><name><surname>Grimble</surname><given-names>RF</given-names></name><name><surname>Lund</surname><given-names>EK</given-names></name></person-group><article-title>The influence of dietary lipids on the composition and membrane fluidity of rat hepatocyte plasma membrane</article-title><source>Lipids</source><year>1997</year><volume>32</volume><fpage>179</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">9075208</pub-id></citation></ref><ref id="b38-0020142"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tiwary</surname><given-names>RK</given-names></name><name><surname>Clandinin</surname><given-names>MT</given-names></name><name><surname>Cinader</surname><given-names>B</given-names></name><etal/></person-group><article-title>Effect of high polyunsaturated fat diets on the composition of B cell and T cell membrane lipids</article-title><source>Nutr Res</source><year>1987</year><volume>7</volume><fpage>489</fpage><lpage>498</lpage></citation></ref><ref id="b39-0020142"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chapkin</surname><given-names>TS</given-names></name><name><surname>Carmichael</surname><given-names>SL</given-names></name></person-group><article-title>Effects of dietary n-3 and n-6 polyunsaturated fatty acid on macrophage phospholipids classes and subclasses</article-title><source>Lipids</source><year>1990</year><volume>25</volume><fpage>827</fpage><lpage>834</lpage><pub-id pub-id-type="pmid">2093145</pub-id></citation></ref><ref id="b40-0020142"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>PC</given-names></name></person-group><article-title>Fatty acids, dietary lipids and lymphocyte functions</article-title><source>Biochem Soc Trans</source><year>1995</year><volume>23</volume><fpage>302</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">7672330</pub-id></citation></ref><ref id="b41-0020142"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Endres</surname><given-names>S</given-names></name><name><surname>Ghorbani</surname><given-names>R</given-names></name><name><surname>Kelley</surname><given-names>VE</given-names></name><etal/></person-group><article-title>The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells</article-title><source>N Engl J Med</source><year>1989</year><volume>320</volume><fpage>265</fpage><lpage>271</lpage><pub-id pub-id-type="pmid">2783477</pub-id></citation></ref><ref id="b42-0020142"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Pablo</surname><given-names>MA</given-names></name><name><surname>Ortega</surname><given-names>E</given-names></name><name><surname>Gallego</surname><given-names>AM</given-names></name><name><surname>Alvarez</surname><given-names>C</given-names></name><name><surname>Pancorbo</surname><given-names>PL</given-names></name><name><surname>Alvarez de Cienfuegos</surname><given-names>G</given-names></name></person-group><article-title>The effect of dietary fatty acid manipulation on phagocytic activity and cytokine production by peritoneal cells from Balb/c mice</article-title><source>J Nutr Sci Vitaminol</source><year>1998</year><volume>44</volume><fpage>57</fpage><lpage>67</lpage><pub-id pub-id-type="pmid">9591234</pub-id></citation></ref><ref id="b43-0020142"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Endres</surname><given-names>S</given-names></name></person-group><article-title>N-3 polyunsaturated fatty acids and human cytokine synthesis</article-title><source>Lipids</source><year>1996</year><volume>31</volume><fpage>S239</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">8729126</pub-id></citation></ref><ref id="b44-0020142"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>DR</given-names></name><name><surname>Urakaze</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><etal/></person-group><article-title>Dietary marine lipids suppress continuous expression of interleukin-1&#x003b2; gene expression</article-title><source>Lipids</source><year>1996</year><volume>31</volume><fpage>S23</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">8729089</pub-id></citation></ref><ref id="b45-0020142"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Pablo</surname><given-names>MA</given-names></name><name><surname>Ortega</surname><given-names>E</given-names></name><name><surname>Gallego</surname><given-names>AM</given-names></name><name><surname>Alvarez</surname><given-names>C</given-names></name><name><surname>Pancorbo</surname><given-names>PL</given-names></name><name><surname>Alvarez de Cienfuegos</surname><given-names>G</given-names></name></person-group><article-title>Influence of diets containing olive oil, sunflower oil or hydrogenated coconut oil on the immune response of mice</article-title><source>J Clin Biochem Nutr</source><year>1998</year><volume>25</volume><fpage>11</fpage><lpage>23</lpage></citation></ref><ref id="b46-0020142"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yaqoob</surname><given-names>P</given-names></name><name><surname>Newsholme</surname><given-names>EA</given-names></name><name><surname>Calder</surname><given-names>PC</given-names></name></person-group><article-title>Inhibition of natural killer cell activity by dietary lipids</article-title><source>Immunol Lett</source><year>1994</year><volume>41</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">8002045</pub-id></citation></ref><ref id="b47-0020142"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roder</surname><given-names>JC</given-names></name><name><surname>Klein</surname><given-names>M</given-names></name></person-group><article-title>Target-effector interaction in the natural killer cell system</article-title><source>J Immunol</source><year>1979</year><volume>123</volume><fpage>2785</fpage><lpage>2790</lpage><pub-id pub-id-type="pmid">227959</pub-id></citation></ref><ref id="b48-0020142"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>RA</given-names></name><name><surname>Brahmi</surname><given-names>Z</given-names></name></person-group><article-title>Role of lipooxygenation in natural killer cell activation</article-title><source>J Immunol</source><year>1986</year><volume>136</volume><fpage>1783</fpage><lpage>1790</lpage><pub-id pub-id-type="pmid">3081633</pub-id></citation></ref><ref id="b49-0020142"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramstedt</surname><given-names>U</given-names></name><name><surname>Ng</surname><given-names>J</given-names></name><name><surname>Wigzell</surname><given-names>H</given-names></name><name><surname>Serhan</surname><given-names>CN</given-names></name><name><surname>Samuelsson</surname><given-names>B</given-names></name></person-group><article-title>Action of novel eicosanoids lipoxin A and B on human natural killer cell cytotoxicity. Effects on intracellular cAMP and target cell binding</article-title><source>J Immunol</source><year>1985</year><volume>135</volume><fpage>3434</fpage><lpage>3438</lpage><pub-id pub-id-type="pmid">2995494</pub-id></citation></ref><ref id="b50-0020142"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>PC</given-names></name><name><surname>Bond</surname><given-names>JA</given-names></name><name><surname>Harvey</surname><given-names>DJ</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Newsholme</surname><given-names>EA</given-names></name></person-group><article-title>Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis</article-title><source>Biochem J</source><year>1990</year><volume>269</volume><fpage>807</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">2117922</pub-id></citation></ref><ref id="b51-0020142"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>De Pablo</surname><given-names>MA</given-names></name><name><surname>De Cienfuegos</surname><given-names>GA</given-names></name></person-group><article-title>Modulatory effects of dietary lipids on immune system functions</article-title><source>Immunol Cell Biol</source><year>2000</year><volume>78</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">10651927</pub-id></citation></ref><ref id="b52-0020142"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uhlinger</surname><given-names>DJ</given-names></name><name><surname>Burnham</surname><given-names>DN</given-names></name><name><surname>Mullins</surname><given-names>RE</given-names></name><name><surname>Kalmar</surname><given-names>JR</given-names></name><name><surname>Cutler</surname><given-names>CW</given-names></name><name><surname>Arnold</surname><given-names>RR</given-names></name><name><surname>Lambeth</surname><given-names>JD</given-names></name><name><surname>Merrill</surname><given-names>AH</given-names><suffix>Jr</suffix></name></person-group><article-title>Functional differences in human PMNs isolated pre- and post-prendially</article-title><source>FEBS Lett</source><year>1991</year><volume>286</volume><fpage>28</fpage><pub-id pub-id-type="pmid">1650714</pub-id></citation></ref><ref id="b53-0020142"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Van Dyke</surname><given-names>TE</given-names></name><name><surname>Hosozewicz</surname><given-names>HV</given-names></name><name><surname>Cianciola</surname><given-names>LJ</given-names></name><name><surname>Genco</surname><given-names>RJ</given-names></name></person-group><article-title>Neutrophil chemotaxis dysfunction in human periodontitis</article-title><source>Infect Immun</source><year>1980</year><volume>27</volume><fpage>124</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">7358424</pub-id></citation></ref><ref id="b54-0020142"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>DW</given-names></name><name><surname>Morris</surname><given-names>AL</given-names></name></person-group><article-title>Periodontal manifestations of cyclic neutropenia</article-title><source>J Periodont Res</source><year>1961</year><volume>32</volume><fpage>159</fpage><lpage>168</lpage></citation></ref><ref id="b55-0020142"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cutler</surname><given-names>CW</given-names></name><name><surname>Wasfy</surname><given-names>MO</given-names></name><name><surname>Ghaffar</surname><given-names>K</given-names></name><name><surname>Hosni</surname><given-names>M</given-names></name><name><surname>Bloyd</surname><given-names>DR</given-names></name></person-group><article-title>Impaired bactericidal activity of PMN from two brothers with necrotizing ulcerative gingivo-periodontitis</article-title><source>J Periodontol</source><year>1993</year><volume>65</volume><fpage>357</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">8195981</pub-id></citation></ref><ref id="b56-0020142"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Croft</surname><given-names>KD</given-names></name><name><surname>Beilin</surname><given-names>LJ</given-names></name><name><surname>Vandongen</surname><given-names>R</given-names></name><name><surname>Rouse</surname><given-names>I</given-names></name><name><surname>Masarei</surname><given-names>J</given-names></name></person-group><article-title>Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia</article-title><source>Atherosclerosis</source><year>1990</year><volume>83</volume><fpage>101</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">2173612</pub-id></citation></ref><ref id="b57-0020142"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krause</surname><given-names>S</given-names></name><name><surname>Pohl</surname><given-names>A</given-names></name><name><surname>Pohl</surname><given-names>C</given-names></name><name><surname>Liebrenz</surname><given-names>A</given-names></name><name><surname>Ruhling</surname><given-names>K</given-names></name><name><surname>Losche</surname><given-names>W</given-names></name></person-group><article-title>Increased generation of reactive oxygen species in mononuclear blood cells from hypercholesterolemic patients</article-title><source>Thromb Res</source><year>1993</year><volume>71</volume><fpage>237</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">8211889</pub-id></citation></ref><ref id="b58-0020142"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krause</surname><given-names>S</given-names></name><name><surname>Brachmann</surname><given-names>P</given-names></name><name><surname>Brandes</surname><given-names>C</given-names></name><name><surname>Losche</surname><given-names>W</given-names></name><name><surname>Hoffmann</surname><given-names>T</given-names></name><name><surname>Gangler</surname><given-names>P</given-names></name></person-group><article-title>Aggregation behavior of blood granulocytes in patients with periodontal disease</article-title><source>Arch Oral Biol</source><year>1990</year><volume>35</volume><fpage>75</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">2390026</pub-id></citation></ref><ref id="b59-0020142"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>K</given-names></name></person-group><article-title>Histological studies on the Wistar rats fed cholesterol, sodium cholate and methylthiouracil, with special reference to the changes of the periodontal tissues</article-title><source>Kokubyo Gakkai Zasshi</source><year>1965</year><volume>32</volume><fpage>368</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">5222238</pub-id></citation></ref><ref id="b60-0020142"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maglakelidze</surname><given-names>N</given-names></name><name><surname>Galogre</surname><given-names>A</given-names></name><name><surname>Tsagareli</surname><given-names>Z</given-names></name></person-group><article-title>Functional-morphologic aspects of changes of mucosal gingiva microcirculatory bed vessels in experimental gingivitis against the background of hypercholesterolemia</article-title><source>Georgian Med News</source><year>2005</year><volume>4</volume><fpage>71</fpage><lpage>74</lpage></citation></ref><ref id="b61-0020142"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ebersole</surname><given-names>JL</given-names></name><name><surname>Cappelli</surname><given-names>D</given-names></name><name><surname>Mott</surname><given-names>GE</given-names></name><name><surname>Kesavalu</surname><given-names>L</given-names></name><name><surname>Holt</surname><given-names>SC</given-names></name><name><surname>Singer</surname><given-names>RE</given-names></name></person-group><article-title>Systemic manifestations of periodontitis in the non-human primate</article-title><source>J Periodont Res</source><year>1999</year><volume>34</volume><fpage>358</fpage><lpage>362</lpage><pub-id pub-id-type="pmid">10685361</pub-id></citation></ref><ref id="b62-0020142"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f6;sche</surname><given-names>W</given-names></name><name><surname>Karapetow</surname><given-names>F</given-names></name><name><surname>Pohl</surname><given-names>A</given-names></name><name><surname>Pohl</surname><given-names>C</given-names></name><name><surname>Kocher</surname><given-names>T</given-names></name></person-group><article-title>Plasma lipid and blood glucose levels in patients with destructive periodontal disease</article-title><source>J Clin Periodontol</source><year>2000a</year><volume>27</volume><fpage>537</fpage><lpage>541</lpage></citation></ref><ref id="b63-0020142"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f6;sche</surname><given-names>W</given-names></name><name><surname>Karapetow</surname><given-names>F</given-names></name><name><surname>Pohl</surname><given-names>A</given-names></name><name><surname>Krause</surname><given-names>S</given-names></name><name><surname>Kocher</surname><given-names>T</given-names></name></person-group><article-title>Plasmalipide, blutglucose und PAF-Acetylhydrolase bei marginaler paradontitis</article-title><source>Deutsche Zahn&#x000e4;rztliche Zeitschrift</source><year>2000b</year><volume>55</volume><fpage>431</fpage><lpage>434</lpage></citation></ref><ref id="b64-0020142"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>I</given-names></name><name><surname>Tidehag</surname><given-names>P</given-names></name><name><surname>Lundberg</surname><given-names>V</given-names></name><name><surname>Hallmans</surname><given-names>G</given-names></name></person-group><article-title>Dental status, diet and cardiovascular risk factors in middle-aged people in northern Sweden</article-title><source>Community Dent Oral Epidemiol</source><year>1994</year><volume>22</volume><fpage>431</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">7882658</pub-id></citation></ref><ref id="b65-0020142"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wakai</surname><given-names>K</given-names></name><name><surname>Kawamura</surname><given-names>T</given-names></name><name><surname>Umemura</surname><given-names>O</given-names></name><name><surname>Hara</surname><given-names>Y</given-names></name><name><surname>Machida</surname><given-names>J</given-names></name><name><surname>Anno</surname><given-names>T</given-names></name><name><surname>Ichihara</surname><given-names>Y</given-names></name><name><surname>Mizuno</surname><given-names>Y</given-names></name><name><surname>Tamakoshi</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Ohno</surname><given-names>Y</given-names></name></person-group><article-title>Associations of medical status and physical fitness with periodontal disease</article-title><source>J Clin Periodontol</source><year>1999</year><volume>26</volume><fpage>664</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">10522778</pub-id></citation></ref><ref id="b66-0020142"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T</given-names></name><name><surname>Trevisan</surname><given-names>M</given-names></name><name><surname>Genco</surname><given-names>RJ</given-names></name><name><surname>Falkner</surname><given-names>KL</given-names></name><name><surname>Dorn</surname><given-names>JP</given-names></name><name><surname>Sempos</surname><given-names>CT</given-names></name></person-group><article-title>Examination of the relation between periodontal health and cardiovascular risk factors: Serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen</article-title><source>Am J Epidemiol</source><year>2000a</year><volume>121</volume><fpage>273</fpage><lpage>282</lpage></citation></ref><ref id="b67-0020142"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>J</given-names></name><name><surname>Chaushu</surname><given-names>G</given-names></name><name><surname>Sharabi</surname><given-names>V</given-names></name></person-group><article-title>On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease</article-title><source>J Clin Periodontol</source><year>2001</year><volume>28</volume><fpage>865</fpage><lpage>868</lpage><pub-id pub-id-type="pmid">11493357</pub-id></citation></ref><ref id="b68-0020142"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>J</given-names></name><name><surname>Flugelman</surname><given-names>MY</given-names></name><name><surname>Golberg</surname><given-names>A</given-names></name><name><surname>Heft</surname><given-names>M</given-names></name></person-group><article-title>Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels</article-title><source>J Periodontol</source><year>2002</year><volume>73</volume><fpage>494</fpage><lpage>500</lpage><pub-id pub-id-type="pmid">12027250</pub-id></citation></ref><ref id="b69-0020142"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buhlin</surname><given-names>K</given-names></name><name><surname>Gustafson</surname><given-names>A</given-names></name><name><surname>Pockley</surname><given-names>AG</given-names></name><name><surname>Frostegard</surname><given-names>J</given-names></name><name><surname>Klinge</surname><given-names>B</given-names></name></person-group><article-title>Risk factors for cardiovascular disease in patients with periodontitis</article-title><source>Eur Heart J</source><year>2003</year><volume>24</volume><fpage>2099</fpage><lpage>2107</lpage><pub-id pub-id-type="pmid">14643270</pub-id></citation></ref><ref id="b70-0020142"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morita</surname><given-names>M</given-names></name><name><surname>Horiuchi</surname><given-names>M</given-names></name><name><surname>Kinoshita</surname><given-names>Y</given-names></name><name><surname>Yamamato</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>T</given-names></name></person-group><article-title>Relationship between blood triglyceride levels and periodontal status</article-title><source>Community Dent Health</source><year>2004</year><volume>21</volume><fpage>32</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">15074870</pub-id></citation></ref><ref id="b71-0020142"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cutler</surname><given-names>CW</given-names></name><name><surname>Shinedling</surname><given-names>EA</given-names></name><name><surname>Nunn</surname><given-names>M</given-names></name><name><surname>Jotwani</surname><given-names>R</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Nares</surname><given-names>S</given-names></name><name><surname>Iacopino</surname><given-names>AM</given-names></name></person-group><article-title>Association between periodontitis and hyperlipidemia: cause or effect?</article-title><source>J Periodontol</source><year>1999b</year><volume>70</volume><fpage>1429</fpage><lpage>1434</lpage><pub-id pub-id-type="pmid">10632517</pub-id></citation></ref><ref id="b72-0020142"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uchiumi</surname><given-names>D</given-names></name><name><surname>Kobayashi</surname><given-names>M</given-names></name><name><surname>Tachikawa</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name></person-group><article-title>Subcutaneous and continuous administration of lipopolysaccharide increases serum levels of triglyceride and monocyte chemoattractant protein-1 in rats</article-title><source>J Periodont Res</source><year>2004</year><volume>39</volume><fpage>120</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">15009520</pub-id></citation></ref><ref id="b73-0020142"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pussinen</surname><given-names>PJ</given-names></name><name><surname>Jauhiainen</surname><given-names>M</given-names></name><name><surname>Vilkuna-Rautiainen</surname><given-names>T</given-names></name><name><surname>Sundvall</surname><given-names>J</given-names></name><name><surname>Vesanen</surname><given-names>M</given-names></name><name><surname>Mattila</surname><given-names>K</given-names></name><name><surname>Palosuo</surname><given-names>T</given-names></name><name><surname>Alfthan</surname><given-names>G</given-names></name><name><surname>Asikainen</surname><given-names>S</given-names></name></person-group><article-title>Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide</article-title><source>Arterioscler Thromb Vasc Biol</source><year>2004</year><volume>24</volume><fpage>2174</fpage><lpage>2180</lpage><pub-id pub-id-type="pmid">15388525</pub-id></citation></ref><ref id="b74-0020142"><label>74</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pussinen</surname><given-names>PJ</given-names></name><name><surname>Jauhiainen</surname><given-names>M</given-names></name><name><surname>Vilkuna-Rautiainen</surname><given-names>T</given-names></name><name><surname>Sundvall</surname><given-names>J</given-names></name><name><surname>Vesanen</surname><given-names>M</given-names></name><name><surname>Mattila</surname><given-names>K</given-names></name><name><surname>Palosuo</surname><given-names>T</given-names></name><name><surname>Alfthan</surname><given-names>G</given-names></name><name><surname>Asikainen</surname><given-names>S</given-names></name></person-group><article-title>Periodontitis decreases the antiatherogenic potency of high density lipoprotein</article-title><source>J Lipid Res</source><year>2004</year><volume>45</volume><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">13130123</pub-id></citation></ref><ref id="b75-0020142"><label>75</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f6;sche</surname><given-names>W</given-names></name><name><surname>Marshai</surname><given-names>GJ</given-names></name><name><surname>Apatzidou</surname><given-names>DA</given-names></name><name><surname>Krause</surname><given-names>S</given-names></name><name><surname>Kocher</surname><given-names>T</given-names></name><name><surname>Kinane</surname><given-names>DF</given-names></name></person-group><article-title>Lipoprotein-associated phospholipase A2 and plasma lipids in patients with destructive periodontal disease</article-title><source>J Clin Periodontol</source><year>2005</year><volume>32</volume><fpage>640</fpage><lpage>644</lpage><pub-id pub-id-type="pmid">15882224</pub-id></citation></ref><ref id="b76-0020142"><label>76</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;aiuto</surname><given-names>F</given-names></name><name><surname>Nibali</surname><given-names>L</given-names></name><name><surname>Parkar</surname><given-names>M</given-names></name><name><surname>Suvan</surname><given-names>J</given-names></name><name><surname>Tonetti</surname><given-names>MS</given-names></name></person-group><article-title>Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol</article-title><source>J Dent Res</source><year>2005</year><volume>84</volume><fpage>269</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">15723869</pub-id></citation></ref><ref id="b77-0020142"><label>77</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cutler</surname><given-names>CW</given-names></name><name><surname>Machen</surname><given-names>RL</given-names></name><name><surname>Jotwani</surname><given-names>R</given-names></name><name><surname>Iacopino</surname><given-names>AM</given-names></name></person-group><article-title>Heightened gingival inflammation and attachment loss in type 2 diabetics with hyperlipidemia</article-title><source>J Periodontol</source><year>1999a</year><volume>70</volume><fpage>1313</fpage><lpage>1321</lpage><pub-id pub-id-type="pmid">10588494</pub-id></citation></ref><ref id="b78-0020142"><label>78</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noack</surname><given-names>B</given-names></name><name><surname>Jachmann</surname><given-names>I</given-names></name><name><surname>Roscher</surname><given-names>S</given-names></name><name><surname>Sieber</surname><given-names>L</given-names></name><name><surname>Kopprasch</surname><given-names>S</given-names></name><name><surname>Luck</surname><given-names>C</given-names></name><name><surname>Hanefeld</surname><given-names>M</given-names></name><name><surname>Hoffmann</surname><given-names>T</given-names></name></person-group><article-title>Metabolic diseases and their possible link to risk indicators of periodontitis</article-title><source>J Periodontol</source><year>2000</year><volume>71</volume><fpage>898</fpage><lpage>903</lpage><pub-id pub-id-type="pmid">10914792</pub-id></citation></ref></ref-list></back></article>